tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
ADAP is currently covered by 4 analysts
Adaptimmune Therapeutics Plc's activity chart (see below) currently has 17 price targets and 22 ratings on display. The stock rating distribution of ADAP is 25% HOLD, 50% BUY and 25% SELL.
Analysts average stock forecasts to be materialized ratio is 39% with an average time for these price targets to be met of 270 days.
Highest price target for ADAP is $2, Lowest price target is $1.
Most recent stock forecast was given by PETER LAWSON from BARCLAYS on 10-Aug-2023. First documented stock forecast 30-Sep-2016.
Currently out of the existing stock ratings of ADAP, 1 are a HOLD (25%), 2 are a BUY (50%), 1 are a SELL (25%).
3/31/00 2 for 1
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell
$1
$-0.01 (-0.99%)
$4
3 years 1 months 23 days ago
(10-Aug-2023)
3/4 (75%)
$0.18 (21.95%)
245
Buy
$5
$3.99 (395.05%)
3 years 9 months ago
(03-Jan-2023)
0/2 (0%)
$3.33 (199.40%)
Buy
$9
$8.22 (1053.85%)
$9
3 years 10 months 24 days ago
(09-Nov-2022)
2/3 (66.67%)
$1.29 (98.13%)
340
Hold
$3
$1.99 (197.03%)
4 years 4 months 24 days ago
(09-May-2022)
1/5 (20%)
$1.46 (94.81%)
377
Buy
$6
$5.22 (669.23%)
$16
7 years 4 months 26 days ago
(07-May-2019)
1/3 (33.33%)
$6.36 (92.59%)
388
What is ADAP (Adaptimmune Therapeutics Plc) average time for price targets to be met?
Which analyst most recently updated their price target on ADAP (Adaptimmune Therapeutics Plc)?
Which analyst has the current lower performing score on ADAP (Adaptimmune Therapeutics Plc) with a proven track record?
Which analyst has the most public recommendations on ADAP (Adaptimmune Therapeutics Plc)?
Which analyst is the currently most bullish on ADAP (Adaptimmune Therapeutics Plc)?
Which analyst is the currently most reserved on ADAP (Adaptimmune Therapeutics Plc)?
